Theratechnologies Inc.
THTX
$2.77
-$0.05-1.77%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.71M | -8.31M | -3.16M | -7.00M | -18.00M |
| Total Depreciation and Amortization | 2.74M | 2.76M | 2.84M | 3.22M | 2.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.96M | 12.94M | 5.23M | 3.35M | 3.86M |
| Change in Net Operating Assets | -18.64M | -5.02M | -6.41M | -356.00K | 7.19M |
| Cash from Operations | -5.66M | 2.38M | -1.50M | -775.00K | -4.05M |
| Capital Expenditure | -3.00K | -- | 0.00 | -15.00K | -96.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.09M | 942.00K | 918.00K | 712.00K | 1.66M |
| Cash from Investing | -6.09M | 942.00K | 918.00K | 697.00K | 1.57M |
| Total Debt Issued | 50.00M | 45.00M | 0.00 | 20.00M | 20.00M |
| Total Debt Repaid | -65.46M | -65.39M | -2.17M | -27.93M | -27.90M |
| Issuance of Common Stock | -- | -- | 25.16M | 25.16M | 25.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.09M | -1.09M | -2.68M | -2.97M | -2.60M |
| Cash from Financing | -16.55M | -21.49M | 20.31M | 14.27M | 14.66M |
| Foreign Exchange rate Adjustments | -37.00K | -32.00K | -5.00K | 22.00K | 34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.34M | -18.20M | 19.72M | 14.21M | 12.22M |